Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector

Molecular Therapy

Volumn 15, Issue 4, 2007, Pages 801-809

  Evans Galea, Marguerite V ^a   Wielgosz, Matthew M ^a   Hanawa, Hideki ^b   Srivastava, Deo Kumar ^a   Nienhuis, Arthur W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ARTICLE; BLOOD DISEASE; CELL CLONE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; GENOTOXICITY; HUMAN; HUMAN CELL; INSULATOR ELEMENT; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; LYMPHOID CELL; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RISK ASSESSMENT; SAFETY; STEM CELL; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CHICKENS; CHROMOSOMES, HUMAN; CLONE CELLS; DNA PRIMERS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GLOBINS; HUMANS; INSULATOR ELEMENTS; JURKAT CELLS; LENTIVIRUS; LYMPHOCYTES; MUTAGENESIS, INSERTIONAL; SAFETY; VIRUS INTEGRATION;

EID: 33947272049     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300103     Document Type: Article

References (43)

1. Cavazzana-Calvo, M, Hacein-Bey, S, de Saint Basile, G, Gross, F, Yvon, E, Nusbaum, P et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
2. Hacein-Bey-Abina, S, LeDeist, F, Carlier, F, Bouneaud, C, Hue, C, DeVillartay, J et al. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346: 1185-1193.
3. Gaspar, H, Parsley, K, Howe, S, King, D, Gilmour, K, Sinclair, J et al. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gamma-retroviral vector. Lancet 364: 2181-2187.
4. Aiuti, A, Slavin, S, Aker, M, Ficara, F, Deola, S, Mortellaro, A et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
5. Ott, M, Schmidt, M, Schwarzwaelder, K, Stein, S, Silver, U, Koehl, U et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
6. Hacein-Bey-Abina, S, von Kalle, C, Schmidt, M, McCormack, M, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
7. Check, E (2005). Gene therapy put on hold as third child develops cancer. Nature 433: 561.
8. Frederickson, RM (2005). Report from the 2nd Stem Cell Clonality and Genotoxicity Retreat. Mol Ther 12: 379-383.
9. Nienhuis, AW, Dunbar, CE and Sorrentino, BP (2006). Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 18: 1031-1049.
10. Yu, SF, von Ruden, T, Kantoff, P, Garber, C, Seiberg, M, Ruther, U et al. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 83: 3194-3198.
11. Zufferey, R, Dull, T, Mandel, R, Bukovsky, A, Quiroz, D, Naldini, L et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880.
12. Felsenfeld, G, Burgess-Beusse, B, Farrell, C, Gaszner, M, Ghirlando, R, Huang, S et al. (2004). Chromatin boundaries and chromatin domains. Cold Spring Harb Symp Quant Biol 69: 245-250.
13. Gaszner, M and Felsenfeld, G (2006). Insulators: Exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7: 703-713.
14. Recillas-Targa, F, Pikaart, M, Burgess-Beusse, B, Bell, A, Litt, M, West, A et al. (2002). Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc Natl Acad Sci USA 99: 6883-6888.
15. Ramezani, A, Hawley, TS and Hawley, RG (2003). Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 101: 4717-4724.
16. Emery, DW, Yannaki, E, Tubb, J, Nishino, T, Li, O and Stamatoyannopoulos, G (2002). Development of virus vectors for gene therapy of beta chain hemoglobinopathies: Flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo. Blood 100: 2012-2019.
17. Puthenveetil, G, Scholes, J, Carbonell, D, Qureshi, N, Xia, P, Zeng, L et al. (2004). Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood 104: 3445-3453.
18. Rivella, S, Callegari, JA, May, C, Tan, CW and Sadelain, M (2000). The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol 74: 4679-4687.
19. Strom, TS, Li, X, Cunningham, JM and Nienhuis, AW (2002). Correction of the murine Wiskott-Aldrich syndrome phenotype by hematopoietic stem cell transplantation. Blood 99: 4626-4628.
20. Strom, TS, Gabbard, W, Kelly, PF, Cunningham, JM and Nienhuis, AW (2003). Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther 10: 803-809.
21. Strom, TS, Turner, S, Andreansky, S, Liu, H, Doherty, P, Srivastava, K et al. (2003). Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood 102: 3108-3116.
22. Hanawa, H, Kelly, P, Nathwani, A, Persons, D, Vandergriff, J, Hargrove, P et al. (2002). Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5: 242-251.
23. Hanawa, H, Persons, DA and Nienhuis, AW (2005). Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors. J Virol 79: 8410-8421.
24. Laufs, S, Gentner, B, Nagy, Z, Jauch, A, Benner, A, Naundorf, S et al. (2003). Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 101: 2191-2198.
25. Mitchell, R, Beitzel, B, Schroder, A, Shinn, P, Chen, H, Berry, C et al. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PloS Biol 2: 1127-1137.
26. Schroder, AR, Shinn, P, Chen, H, Berry, C, Ecker, JR and Bushman, F (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
27. Wu, X, Li, Y, Crise, B, Burgess, SM and Munroe, DJ (2005). Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J Virol 79: 5211-5214.
28. Rao, CR (1973). Linear Statistical Inference and Its Applications. John Wiley & Sons: New York.
29. Lai, WS, Carballo, E, Thorn, JM, Kennington, EA and Blackshear, PJ (2000). Interactions of CCCH zinc finger proteins with mRNA: Binding of tristetraprolin-related zinc finger protein to Au-rich elements and destabilization of mRNA. J Biol Chem 275: 17827-17837.
30. Hall, TM (2005). Multiple modes of RNA recognition by zinc finger proteins. Curr Opin Struct Biol 15: 367-373.
31. Koochekpour, S, Zhang, Y, Beroukhim, R, Hsieh, C, Hofer, M, Zhau, H et al. (2005). Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 44: 351-364.
32. Ciuffi, A and Bushman, FD (2006). Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet 22: 388-395.
33. Sherman, MP and Greene WC (2002). Slipping through the door: HIV entry into the nucleus. Microbes Infect 4: 67-73.
34. Ciuffi, A, Llano, M, Poeschla, E, Hoffmann, C, Leipzig, J, Shinn, P et al. (2005). A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11: 1287-1289.
35. Bushman, F, Lewinski, M, Ciuffi, A, Barr, S, Leipzig, J, Hannenhalli, S et al. (2005). Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 3: 848-858.
36. Hematti, P, Hong, BK, Ferguson, C, Adler, R, Hanawa, H, Sellers S et al. (2004). Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol 2: E423.
37. Du, Y, Jenkins, NA and Copeland, NG (2005). Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106: 3932-3939.
38. Kustikova, O, Fehse, B, Modlich, U, Yang, M, Dullmann, J, Kamino, K et al. (2005). Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308: 1171-1174.
39. Stamatoyannopoulos, G (2005). Control of globin gene expression during development and erythroid differentiation. Exp Hematol 33: 259-271.
40. Truffinet, V, Guglielmi, L, Cogne, M and Denizot, Y (2003). The chicken beta-globin HS4 insulator is not a silver bullet to obtain copy-number dependent expression of transgenes in stable B cell transfectants. Immunol Lett 89: 119-123.
41. Nienhuis, AW (2006). Assays to evaluate the genotoxicity of retroviral vectors. Mol Ther 14: 459-460.
42. Ryu, BY, Gray, JT, Bodine, DM and Nienhuis, AW (2006). Activation of the LM02 gene in human lymphoid cells by rAAV-mediated targeted insertion of a single LTR expression cassette into the first intron. Mol Ther 11: S42.
43. Shou, Y, Stepanova, L and Sorrentino, BP (2005). Mouse models for the analysis of genetic risk factors for hematopoietic transformation in XSCID gene therapy. Mol Ther 11: S176.